VEGFA and wet macular degeneration: Specifically, anti-VEGF agents are commonly used to manage retinal diseases characterized by neovascularization, including but not limited to wet age-related macular degeneration (wet AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and ischemic retinal vein occlusion (RVO) [6].